NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

So, taken from diagnosis or surgery, 82 / 70 is just your guess, right, for DCVax trial (a double blind P3) whole population OS12?
Seeing as it's not a known figure.

And where do you place median Day 0 in the Inovio trial, in relation to diagnosis? It's probably between 4 and 8 weeks, imo.

As to maintenance TMZ in the Inovio trial, you're correct on unmeth not getting it.
But for meth; patients get it, if 'clinically indicated'. So that's probably most of them. Not that that necessarily offers an advantage over not getting it.

And though several of us have already scrutinised it, here is the link for the Inovio trial CT listing, to make it simple for others to look at it.

https://clinicaltrials.gov/ct2/show/NCT03491683?term=inovio&cond=glioblastoma&draw=2&rank=1